CannTrust Risks Losing Half of its Inventory Worth Over $50 Million and NYSE De-listing

While awaiting Health Canada's review over unlicensed cannabis growing in that took place in its Pelham greenhouse last year, CannTrust Holdings voluntarily initiated an internal cease trade policy.

The Ontario Securities Commission has now formalized CannTrust's informal policy with a Management Cease Trade Order that was filled after the company missed the August 14 quarterly financial reporting date.

Although this does not affect most of CannTrust's shareholders, company executives and directors will not be allowed to trade securities until 2 days after the company files its quarterly reports.

The filing was delayed as CannTrust awaits Health Canada's Decision pending review completion, which could lead to a total loss of the company's license or include orders to destroy a substantial portion of organic assets.

After forming a committee to investigate unlicensed growing and firing CEO Peter Aceto, the company, in a statement, said that it was in the process of preparing a remediation plan to submit to Health Canada. Health Canada is yet to provide guidance regarding the timing or the content of its resolve.

In an update to stockholders, CannTrust noted that Health Canada's decision could impact over half of its current inventory. This translates to more than $50 million in assets.

The uncertainty on whether the company's license will be revoked or if its products will be destroyed is causing CannTrust more troubles with the New York Stock Exchange (NYSE).

Now with the financial reporting compliance issues, the NYSE has given CannTrust 6 months to file proper reports. Failure to do this could lead to delisting the company from the exchange.

Besides missing out on exclusive business deals, CannTrust's financial woes are not likely to end soon, even if it survives the review by Health Canada.

Investors who acquired shares in CannTrust from the time unlicensed growing began in October 2018 through early July this year when it was revealed to the public have already started Class Action Lawsuits.

Elison Grey

Elison Grey is one of our up and coming researchers who has a Bachelor’s Degree in Literature and Humanities, as well as being a Licensed Clinical Massage Therapist. She finds comfort in writing about overall health and wellness, diet and nutrition, natural medicine and alternative therapy methods.

Share

Recent Posts

  • Gummies

Condor CBD Gummies – Shocking Customer Scam Concerns?

The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…

2 years ago
  • Guides

Best Delta 8 THC Products – And Why You Need To Try Them

Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…

3 years ago
  • Guides

VidaCap: What To Know About the Best Mushroom Supplements Brand

With more people turning towards natural remedies in recent years, mushroom supplements have taken the…

3 years ago
  • Topicals & Salves

Circle Labs CBD: Legit Hemp Pain Relief Balm That Works?

The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…

3 years ago
  • Gummies

Kara’s Orchards CBD Gummies: Safe Full Spectrum Hemp Extract

If anyone is looking for a CBD supplement that is packed with all the necessary…

3 years ago
  • Tinctures & Drops

Sage Elixir CBD: Legit Sage Elixir CBD Oil Tincture or Not?

If anyone has been searching the internet for all the benefits of CBD and where…

3 years ago